ClinicalTrials.Veeva

Menu

The Influence of Covid-19 on the Audio-vestibular System

H

HaEmek Medical Center, Israel

Status

Unknown

Conditions

Covid19

Treatments

Diagnostic Test: Audio-Vestibular evaluation

Study type

Interventional

Funder types

Other

Identifiers

NCT04709146
0226-20-EMC

Details and patient eligibility

About

the study's porpuse is to examine whether Covid-19 causese a reduction in sensorineural hearing and vestibular function in recovered pateints - compared to healthy controls.

Both study groups will undergo audiometry, tympanometry, Video Head Impulse testing, Subjective Visual Vertigo testing and Video-Nystamography.

Previous audiometry results will also be aquired.

Enrollment

70 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • ages 18-80 performed audiometry testing in the last two years

Exclusion criteria

  • known inner ear dysfunction - Sudden sensorineural hearing loss; autoimmune disease (Cogan's syndrom, SLE, ect.), familial/genetic sensorineural hearing loss, excessive noise exposure.

knowm conductive hearing loss (Air-bone gap>10dB) prior ear surgery chronic tympanic membrane perforation.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

70 participants in 2 patient groups

Recovered Covid-19 patients
Other group
Description:
Diagnostic evulation with audiometry, Tympanography, SVV, VHIT, VNG.
Treatment:
Diagnostic Test: Audio-Vestibular evaluation
Healthy Control
Other group
Description:
Diagnostic evulation with audiometry, Tympanography, SVV, VHIT, VNG.
Treatment:
Diagnostic Test: Audio-Vestibular evaluation

Trial contacts and locations

0

Loading...

Central trial contact

Yoni Evgeni Gutkovich, M.D/Ph.D; Miki Paker, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems